These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17569121)

  • 1. Assessment of hepatic fibrosis in pediatric cases with hepatitis C virus in Egypt.
    El-Hawary MA; El-Raziky MS; Esmat G; Soliman H; Abouzied A; El-Raziky M; El-Akel W; El-Sayed R; Shebl F; Shaheen AA; El-Karaksy H
    World J Gastroenterol; 2007 May; 13(20):2846-51. PubMed ID: 17569121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological evolution of hepatitis C virus-"Healthy carriers".
    Sobesky R; Lebray P; Nalpas B; Vallet-Pichard A; Fontaine H; Lagneau JL; Pol S
    World J Gastroenterol; 2008 Jun; 14(24):3861-5. PubMed ID: 18609710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.
    Poynard T; Bedossa P; Opolon P
    Lancet; 1997 Mar; 349(9055):825-32. PubMed ID: 9121257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
    Shahid M; Idrees M; Nasir B; Raja AJ; Raza SM; Amin I; Rasul A; Tayyab GU
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):788-94. PubMed ID: 24781355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Course of viral hepatitis B and combined B and C hepatitis in children treated for neoplastic diseases.
    Kołtan S; Wysocki M; Kołtan A; Swiatkiewicz V; Styczyński J; Debski R; Balcar-Boroń A
    Med Sci Monit; 2002 Apr; 8(4):CR274-9. PubMed ID: 11951070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartate transaminase to platelet ratio index in hepatitis C virus and Schistosomiasis coinfection.
    Derbala M; Elbadri ME; Amer AM; AlKaabi S; Sultan KH; Kamel YM; Elsayed EH; Avades TY; Chandra P; Shebl FM
    World J Gastroenterol; 2015 Dec; 21(46):13132-9. PubMed ID: 26674154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive markers and predictors of severity of hepatic fibrosis in HCV patients at Sharkia Governorate, Egypt.
    el-Shorbagy E; Afefy AF; Ibrahem IA; Mangoud AM; Eissa MH; Sabee EI; Mahrous S; Abdel-Monem A; Ismail A; Morsy TA; Etewa S; Nor Edin E; Mostafa Y; Abouel-Magd Y; el-Sedawy M; Ragab H; el-Tokhy H; Hassan MI; Lakouz K; Abdel-Aziz K; el-Hady G; Saber M
    J Egypt Soc Parasitol; 2004 Apr; 34(1 Suppl):459-78. PubMed ID: 15124753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrosis Progression in Paired Liver Biopsies from HIV/HCV-Coinfected Patients without Prior Treatment of Hepatitis C.
    Leite AG; Duarte MI; Mendes-Correa MC
    J Int Assoc Provid AIDS Care; 2015; 14(5):463-8. PubMed ID: 26056147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hepatitis C virus genotype 3 in liver fibrosis progression--a systematic review and meta-analysis.
    Probst A; Dang T; Bochud M; Egger M; Negro F; Bochud PY
    J Viral Hepat; 2011 Nov; 18(11):745-59. PubMed ID: 21992794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study on hepatic iron overload in chronic hepatitis C patients].
    Bomfim EA; Pereirade de Oliveira AC; Paraná R; Schinoni MI
    Acta Gastroenterol Latinoam; 2013 Sep; 43(3):212-7. PubMed ID: 24303687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation.
    Angelucci E; Muretto P; Nicolucci A; Baronciani D; Erer B; Gaziev J; Ripalti M; Sodani P; Tomassoni S; Visani G; Lucarelli G
    Blood; 2002 Jul; 100(1):17-21. PubMed ID: 12070002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of laboratory parameters with viral factors in patients with hepatitis C.
    Ijaz B; Ahmad W; Javed FT; Gull S; Sarwar MT; Kausar H; Asad S; Jahan S; Khaliq S; Shahid I; Sumrin A; Hassan S
    Virol J; 2011 Jul; 8():361. PubMed ID: 21777434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of possible clinical and laboratory predictors of liver fibrosis in hemodialysis patients infected with hepatitis C virus.
    Boyacioğlu S; Gür G; Yilmaz U; Korkmaz M; Demirhan B; Bilezikçi B; Ozdemir N
    Transplant Proc; 2004; 36(1):50-2. PubMed ID: 15013298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity.
    Mathurin P; Moussalli J; Cadranel JF; Thibault V; Charlotte F; Dumouchel P; Cazier A; Huraux JM; Devergie B; Vidaud M; Opolon P; Poynard T
    Hepatology; 1998 Mar; 27(3):868-72. PubMed ID: 9500720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus infection in Egyptian children: single centre experience.
    El-Raziky MS; El-Hawary M; El-Koofy N; Okasha S; Kotb M; Salama K; Esmat G; El-Raziky M; Abouzied AM; El-Karaksy H
    J Viral Hepat; 2004 Sep; 11(5):471-6. PubMed ID: 15357655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive assessment of hepatic fibrosis and necroinflammatory activity in Egyptian children with chronic hepatitis C virus infection using FibroTest and ActiTest.
    El-Shabrawi MH; Mohsen NA; Sherif MM; El-Karaksy HM; Abou-Yosef H; El-Sayed HM; Riad H; Bahaa N; Isa M; El-Hennawy A
    Eur J Gastroenterol Hepatol; 2010 Aug; 22(8):946-51. PubMed ID: 20110820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.
    Kelleher TB; Mehta SH; Bhaskar R; Sulkowski M; Astemborski J; Thomas DL; Moore RE; Afdhal NH
    J Hepatol; 2005 Jul; 43(1):78-84. PubMed ID: 15894397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of liver histology in patients with hepatitis C and normal transaminase levels.
    Stanley AJ; Haydon GH; Piris J; Jarvis LM; Hayes PC
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):869-72. PubMed ID: 8889452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.